发明名称 |
Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases |
摘要 |
In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine. |
申请公布号 |
US2014221321(A1) |
申请公布日期 |
2014.08.07 |
申请号 |
US201414170405 |
申请日期 |
2014.01.31 |
申请人 |
Glialogix, Inc. |
发明人 |
Reeder Thaddeus Cromwell;Moore Mark Wade;Lorenz Douglas Alan;Lyon David Keith |
分类号 |
A61K47/32;A61K31/635 |
主分类号 |
A61K47/32 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a patient with progressive multiple sclerosis (P-MS), the method comprising orally administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of sulfasalazine and a pharmaceutically acceptable excipient, wherein the sulfasalazine is in an essentially amorphous form. |
地址 |
Larkspur CA US |